A Multicentre, Open-label, Phase 1/2 Study of IBI133 in Subjects with Unresectable, Locally Advanced or Metastatic Solid Tumours

  • Body, Amy (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date27/03/24 → 26/03/29

Clinical Trial Phase

  • Phase I
  • Phase II